Provided by Tiger Trade Technology Pte. Ltd.

Annexon, Inc.

5.07
-0.1100-2.12%
Post-market: 5.110.0400+0.79%19:49 EDT
Volume:1.43M
Turnover:7.31M
Market Cap:963.30M
PE:-4.50
High:5.28
Open:5.24
Low:5.02
Close:5.18
52wk High:7.18
52wk Low:2.03
Shares:190.00M
Float Shares:164.00M
Volume Ratio:0.51
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1271
EPS(LYR):-1.3445
ROE:-105.26%
ROA:-51.54%
PB:5.18
PE(LYR):-3.77

Loading ...

Annexon Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
May 08

Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), McKesson (MCK) and Alector (ALEC)

TIPRANKS
·
May 08

Annexon Biosciences Q1 net loss narrows as expenses decline

Reuters
·
May 08

Annexon Q1 EPS $(0.23) Beats $(0.29) Estimate

Benzinga Earnings
·
May 08

Annexon Q1 FY26 net loss narrows to $44.1 million

Reuters
·
May 08

Annexon CEO to present at Bank of America Securities Health Care Conference 2026

Reuters
·
May 06

Annexon announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 17

Annexon director William H. Carson acquires $49,600 common shares

Reuters
·
Apr 15

Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal

TIPRANKS
·
Apr 01

Annexon files automatic mixed securities shelf

TIPRANKS
·
Mar 31

Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating

TIPRANKS
·
Mar 31

Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), Innovent Biologics (OtherIVBXF) and Sino Biopharmaceutical (OtherSBMFF)

TIPRANKS
·
Mar 31

Annexon Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Mar 31

Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating

TIPRANKS
·
Mar 31

Annexon reports Q4 EPS (28c), consensus (32c)

TIPRANKS
·
Mar 31

Annexon Q4 EPS $(0.28) Beats $(0.32) Estimate

Benzinga Earnings
·
Mar 31

Annexon FY25 net loss widens 50.9% to $208.5 million; R&D expenses climb to $184.7 million

Reuters
·
Mar 31

Annexon Inc: Anticipated Cash Runway Into Second Half 2027

THOMSON REUTERS
·
Mar 31

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

GlobeNewswire
·
Mar 31